Sign in to edit your profile (add interests, overview, photo, etc.)
    LBNL Profiles Metrics
    22837 Publications
    3073 Total Profiles
    23 Edited Profiles

    Abergel, Rebecca

    TitleChemist Staff Sci/Engr
    SchoolLawrence Berkeley National Lab
    DepartmentChemical Sciences
    Address1 Cyclotron Road
    Berkeley CA 94720
    Phone510/486-5249

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can sign in to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Allred BE, Rupert PB, Gauny SS, An DD, Ralston CY, Sturzbecher-Hoehne M, Strong RK, Abergel RJ. Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides. Proc Natl Acad Sci U S A. 2015 Aug 18; 112(33):10342-7.
        View in: PubMed
      2. Choi TA, Endsley AN, Bunin DI, Colas C, An DD, Morales-Rivera JA, Villalobos JA, Shinn WM, Dabbs JE, Chang PY, Abergel RJ. Biodistribution of the Multidentate Hydroxypyridinonate Ligand [(14) C]-3,4,3-LI(1,2-HOPO), a Potent Actinide Decorporation Agent. Drug Dev Res. 2015 May; 76(3):107-22.
        View in: PubMed
      3. Sturzbecher-Hoehne M, Choi TA, Abergel RJ. Hydroxypyridinonate Complex Stability of Group (IV) Metals and Tetravalent f-Block Elements: The Key to the Next Generation of Chelating Agents for Radiopharmaceuticals. Inorg Chem. 2015 Apr 6; 54(7):3462-8.
        View in: PubMed
      4. Choi TA, Furimsky AM, Swezey R, Bunin DI, Byrge P, Iyer LV, Chang PY, Abergel RJ. In Vitro Metabolism and Stability of the Actinide Chelating Agent 3,4,3-LI(1,2-HOPO). J Pharm Sci. 2015 May; 104(5):1832-8.
        View in: PubMed
      5. Ansoborlo E, Ménager MT, Abergel RJ. 11th international conference on health effects of incorporated radionuclides. Int J Radiat Biol. 2014 Nov; 90(11):945-7.
        View in: PubMed
      6. Liu M, Wang J, Wu X, Wang E, Abergel RJ, Shuh DK, Raymond KN, Liu P. Characterization, HPLC method development and impurity identification for 3,4,3-LI(1,2-HOPO), a potent actinide chelator for radionuclide decorporation. J Pharm Biomed Anal. 2015 Jan 5; 102:443-9.
        View in: PubMed
      7. An DD, Villalobos JA, Morales-Rivera JA, Rosen CJ, Bjornstad KA, Gauny SS, Choi TA, Sturzbecher-Hoehne M, Abergel RJ. (238)Pu elimination profiles after delayed treatment with 3,4,3LI(1,2HOPO) in female and male Swiss-Webster mice. Int J Radiat Biol. 2014 Nov; 90(11):1055-61.
        View in: PubMed
      8. Panyala NR, Sturzbecher-Hoehne M, Abergel RJ. Identification of process related trace level impurities in the actinide decorporation agent 3,4,3-LI(1,2-HOPO): Nozzle-skimmer fragmentation via ESI LC-QTOFMS. J Pharm Biomed Anal. 2014 Nov; 100:157-66.
        View in: PubMed
      9. Sturzbecher-Hoehne M, Kullgren B, Jarvis EE, An DD, Abergel RJ. Highly luminescent and stable hydroxypyridinonate complexes: a step towards new curium decontamination strategies. Chemistry. 2014 Aug 4; 20(32):9962-8.
        View in: PubMed
      10. Deblonde GJ, Sturzbecher-Hoehne M, Abergel RJ. Solution thermodynamic stability of complexes formed with the octadentate hydroxypyridinonate ligand 3,4,3-LI(1,2-HOPO): a critical feature for efficient chelation of lanthanide(IV) and actinide(IV) ions. Inorg Chem. 2013 Aug 5; 52(15):8805-11.
        View in: PubMed
      11. Deblonde GJ, Sturzbecher-Hoehne M, Mason AB, Abergel RJ. Receptor recognition of transferrin bound to lanthanides and actinides: a discriminating step in cellular acquisition of f-block metals. Metallomics. 2013 Jun; 5(6):619-26.
        View in: PubMed
      12. Sturzbecher-Hoehne M, Goujon C, Deblonde GJ, Mason AB, Abergel RJ. Sensitizing curium luminescence through an antenna protein to investigate biological actinide transport mechanisms. J Am Chem Soc. 2013 Feb 20; 135(7):2676-83.
        View in: PubMed
      13. Bunin DI, Chang PY, Doppalapudi RS, Riccio ES, An D, Jarvis EE, Kullgren B, Abergel RJ. Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen. Radiat Res. 2013 Feb; 179(2):171-82.
        View in: PubMed
      14. Kullgren B, Jarvis EE, An DD, Abergel RJ. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions. Toxicol Mech Methods. 2013 Jan; 23(1):18-26.
        View in: PubMed
      15. Correnti C, Clifton MC, Abergel RJ, Allred B, Hoette TM, Ruiz M, Cancedda R, Raymond KN, Descalzi F, Strong RK. Galline Ex-FABP is an antibacterial siderocalin and a lysophosphatidic acid sensor functioning through dual ligand specificities. Structure. 2011 Dec 7; 19(12):1796-806.
        View in: PubMed
      16. Sturzbecher-Hoehne M, Leung CN, D'Aléo A, Kullgren B, Prigent AL, Shuh DK, Raymond KN, Abergel RJ. 3,4,3-LI(1,2-HOPO): in vitro formation of highly stable lanthanide complexes translates into efficacious in vivo europium decorporation. Dalton Trans. 2011 Sep 7; 40(33):8340-6.
        View in: PubMed
      17. Abergel RJ, Raymond KN. Multidentate terephthalamidate and hydroxypyridonate ligands: towards new orally active chelators. Hemoglobin. 2011; 35(3):276-90.
        View in: PubMed
      18. Abergel RJ, Durbin PW, Kullgren B, Ebbe SN, Xu J, Chang PY, Bunin DI, Blakely EA, Bjornstad KA, Rosen CJ, Shuh DK, Raymond KN. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO). Health Phys. 2010 Sep; 99(3):401-7.
        View in: PubMed
      19. Abergel RJ, D'Aléo A, Leung CN, Shuh DK, Raymond KN. Using the antenna effect as a spectroscopic tool: photophysics and solution thermodynamics of the model luminescent hydroxypyridonate complex [Eu(III)(3,4,3-LI(1,2-HOPO))]-. Inorg Chem. 2009 Dec 7; 48(23):10868-70.
        View in: PubMed
      20. Wilson MK, Abergel RJ, Arceneaux JE, Raymond KN, Byers BR. Temporal production of the two Bacillus anthracis siderophores, petrobactin and bacillibactin. Biometals. 2010 Feb; 23(1):129-34.
        View in: PubMed
      21. Abergel RJ, Zawadzka AM, Hoette TM, Raymond KN. Enzymatic hydrolysis of trilactone siderophores: where chiral recognition occurs in enterobactin and bacillibactin iron transport. J Am Chem Soc. 2009 Sep 9; 131(35):12682-92.
        View in: PubMed
      22. Zawadzka AM, Abergel RJ, Nichiporuk R, Andersen UN, Raymond KN. Siderophore-mediated iron acquisition systems in Bacillus cereus: Identification of receptors for anthrax virulence-associated petrobactin . Biochemistry. 2009 Apr 28; 48(16):3645-57.
        View in: PubMed
      23. Hoette TM, Abergel RJ, Xu J, Strong RK, Raymond KN. The role of electrostatics in siderophore recognition by the immunoprotein Siderocalin. J Am Chem Soc. 2008 Dec 24; 130(51):17584-92.
        View in: PubMed
      24. Abergel RJ, Clifton MC, Pizarro JC, Warner JA, Shuh DK, Strong RK, Raymond KN. The siderocalin/enterobactin interaction: a link between mammalian immunity and bacterial iron transport. J Am Chem Soc. 2008 Aug 27; 130(34):11524-34.
        View in: PubMed
      25. Abergel RJ, Zawadzka AM, Raymond KN. Petrobactin-mediated iron transport in pathogenic bacteria: coordination chemistry of an unusual 3,4-catecholate/citrate siderophore. J Am Chem Soc. 2008 Feb 20; 130(7):2124-5.
        View in: PubMed
      26. Abergel RJ, Raymond KN. Terephthalamide-containing ligands: fast removal of iron from transferrin. J Biol Inorg Chem. 2008 Feb; 13(2):229-40.
        View in: PubMed
      27. Abergel RJ, Wilson MK, Arceneaux JE, Hoette TM, Strong RK, Byers BR, Raymond KN. Anthrax pathogen evades the mammalian immune system through stealth siderophore production. Proc Natl Acad Sci U S A. 2006 Dec 5; 103(49):18499-503.
        View in: PubMed
      28. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, Aderem A, Smith KD. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006 Oct 31; 103(44):16502-7.
        View in: PubMed
      29. Abergel RJ, Moore EG, Strong RK, Raymond KN. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition. J Am Chem Soc. 2006 Aug 30; 128(34):10998-9.
        View in: PubMed
      30. Wilson MK, Abergel RJ, Raymond KN, Arceneaux JE, Byers BR. Siderophores of Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis. Biochem Biophys Res Commun. 2006 Sep 15; 348(1):320-5.
        View in: PubMed
      31. Abergel RJ, Warner JA, Shuh DK, Raymond KN. Enterobactin protonation and iron release: structural characterization of the salicylate coordination shift in ferric enterobactin. J Am Chem Soc. 2006 Jul 12; 128(27):8920-31.
        View in: PubMed
      32. Abergel RJ, Raymond KN. Synthesis and thermodynamic evaluation of mixed hexadentate linear iron chelators containing hydroxypyridinone and terephthalamide units. Inorg Chem. 2006 May 1; 45(9):3622-31.
        View in: PubMed
      Rebecca's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors at LBL
      People in Profiles who have published with this person.
      _
      Related Authors at LBL
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP